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To assess the neurotoxic properties of the glutamate agonist quisqualic acid (QA) in immature brain, 
we injected this compound (100 nmol QA/I/11) directly into the striatum of 7-day-old rats. QA produced 
neuronal necrosis and glial infiltration in 14 pups and reduced the size of the striatum and hippocampus 
on the side of injection. Intracerebral injection of QA provides a new method for producing neuronal 
lesions in the developing brain. 
Multiple excitatory amino acid receptor subtypes have been identified in mamma- 
lian brain [13]. N-methyl-D-aspartate (NMDA)-, quisqualic acid (QA)-, and kainic 
acid (KA)-preferring glutamate receptors have been distinguished both by biochemi- 
cal and electrophysiologic criteria. The immature brain is relatively resistant to neu- 
ronal damage from KA, a conformationally restricted glutamate analogue with con- 
vulsant and neurotoxic properties in adult animals [2]. Development of susceptibility 
to excitotoxic lesions from KA with maturity has been correlated with the expression 
of presynaptic markers for corticostriatal glutamate pathways. However, the imma- 
ture brain, both in rats and human infants, contains high concentrations of post- 
synaptic glutamate receptors in the corpus striatum, globus pallidus and hippocam- 
pus. Moreover, in the globus pallidus, which has virtually no glutamate receptors in 
adults, there is a high density of glutamate receptors in 7-day-old rats; these receptors 
disappear over the next two postnatal weeks [5]. In the corpus striatum, glutamate 
receptors reach adult levels by day 7 although the presynaptic glutamate uptake pro- 
cess lags behind. In contrast to the adult striatum, which is enriched in NMDA recep- 
tors, [4], preliminary studies have demonstrated that the immature striatum contains 
a large proportion of QA-preferring glutamate receptors (J.T. Greenamyre, personal 
Correspondence." F.S. Silverstein, Neuroscience Laboratory Building, 1103 E. Huron, Ann Arbor, M1 
48104, U.S.A. 
0304-3940/86/$ 03.50 © 1986 Elsevier Scientific Publishers Ireland Ltd. 
14 
communication). This observation suggested that glutamate agonists which stimulate 
QA receptors might be most potent neurotoxins in the immature brain. In this study, 
we report that direct intracerebral injection of QA causes neuronal destruction in the 
basal ganglia and hippocampus of 7-day-old rats. 
Seven-day-old Sprague-Dawley rats were used for these experiments. Pups were 
briefly anesthetized with ether, positioned in plaster of Paris molds, and placed in 
a stereotaxic apparatus (David Kopf). Coordinates for intrastriatal injection were 
determined initially using surface anatomic landmarks, injecting 1 /ll of copper sul- 
A 
Fig. 1. A: Nissl-stained coronal section of rat brain at the level of  the striatum. On day 7 the animal 
received a l-ltl intrastriatal injection of 0.1 /zmol of  QA dissolved in 0.01 M Tris, pH 7.4. The pup was 
killed on day 12. The size of  the striatum is reduced unilaterally and there is an asymmetric enlargement 
of the lateral ventricle. Within the striatum, along the needle track, the cellular organization is disrupted. 
This unilateral striatal lesion was present in all 14 pups that received QA and in none of the Tris-injected 
controls. B: a more posterior section demonstrates a unilateral hippocampal lesion (details in Fig. 2). S, 
septum: C, caudate; H, hippocampus. 
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fate solution with a Hamilton syringe, and identifying the location of  tissue damage. 
QA (Sigma) was dissolved in 0.01 M Tris, pH 7.4 (final concn., 0.1 M); l /~l (100 
nmol//ll) was injected into the striatum over 5 min (n = 14). In age-matched controls, 
l/~l of diluent was injected (n = 4). All pups were returned to the dam for 5 days and 
on day 12, they were decapitated, the brains were removed, placed into phosphate- 
buffered formalin, and then 50-/~m frozen sections were stained with Cresyl violet. 
Cross-sectional areas of the striatum and hippocampus were determined by outlining 
enlarged images of histologic sections projected on tracing paper, weighing cut-outs 
of the striatum and hippocampus, and comparing their weights with those of cut-outs 
of known cross-sectional area. 
Hypoxic neuronal damage may be mediated by excitatory neurotransmitter release 
[9]. To determine if hypoxic exposure could potentiate the deleterious effects of QA 
in one of the experiments, 5 animals received QA injections alone and 5 litter-mates 
were exposed to an 8% oxygen (02), balanced nitrogen environment for 1.5 h after 
the injection of QA. Normal rat pups tolerate 8% 02 exposure well for many hours. 
While 2/5 QA-injected pups exhibited mild contralateral turning in room air, expo- 
sure to moderate hypoxia markedly enhanced this response. All rats placed in 8% 02 
after QA injections twisted and turned markedly to the left and after 1.5 h of hypoxia 
appeared ill. 
A consistent pathologic lesion was found in all pups which received QA (Fig. 1). 
The size of the corpus striatum was reduced on the side of the injection and there 
was a corresponding unilateral enlargement of the lateral ventricle. High power mi- 
croscopic examination of this area demonstrated abnormal cellular organization, 
neuronal necrosis, and glial infiltration along the needle track and extending into the 
globus pallidus. Unilateral lesions of the hippocampus were observed as well (Figs. 
1B and 2). Areas adjacent to the ventricle were most susceptible to neuronal damage, 
the pyramidal cell layer of CA3 was disrupted and tissue mass was markedly dimin- 
ished. Hippocampal lesions were most likely attributable to leaking of drug into the 
adjacent ventricle; with intrastriatal copper sulfate injections ependymal damage de- 
Fig. 2. Photographs of  Nissl-stained formalin-fixed sections of  hippocampus from a 12-day-old animal. 
On day 7 the pup received a l-/d intrastriatal injection of  0.1 /tmol of  QA. The pup was killed on day 
12. A: on the side of  injection, the tissue adjacent to the lateral ventricle is necrotic and the pyramidal 
cells in regions of  CA3 and CA4 are disrupted. B: the opposite side is intact. Bar=  100 Itm; CA, cornu 
ammonis ,  DG, dentate gyrus. 
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veloped in the adjacent ventricle. In contrast, in controls, tissue integrity was pre- 
served, and the ventricular size was equal bilaterally. 
In QA-treated animals, measurement of the striatal cross-sectional area demon- 
strated consistent tissue loss in the striatum ( - 8.9_+ 1.9% compared with the contra- 
lateral striatum; - 17.5_+ 2.7% compared with control; P < 0.001, Student's t-test; Ta- 
ble I). In the hippocampus ipsilateral to the injection the cross-sectional area was 
reduced (-53-I-9.5% compared with the opposite side; - 7 1  +__7% compared with 
control; P < 0.001, t-test) and the size of the hippocampus contralateral to the injec- 
tion was also reduced (-33_+ 13%; P<0 .05  compared with values in age-matched 
controls). In the striatum the extent of tissue loss was significantly greater in pups 
exposed to hypoxia (-8.9_+ 1.9% vs -22 .3+2.6%;  P<0.005,  t-test). 
These results demonstrate for the first time that a glutamate agonist, QA, is neuro- 
toxic for the immature basal ganglia and hippocampus. In adult rats, QA is relatively 
inactive as a neurotoxin in the striatum [14]. QA may be toxic in 7-day-old rats be- 
cause of the preponderance of the QA receptor sub-type at this age. A recent report 
[8] suggests an additional molecular mechanism for the differential response to gluta- 
mate agonists and perhaps for greater potency of QA in immature brain. Glutamate 
receptor activation stimulates inositol phospholipid hydrolysis. Inositol phosphate 
(PI) and diacyl glycerol are released and these compounds trigger intracellular bio- 
chemical events, e.g. calcium mobilization and arachidonic acid release, which, in 
excess, may contribute to irreversible neuronal damage. In vitro, in hippocampal tis- 
sue from 7-day-old pups, QA is one of the most potent stimuli of PI turnover. Ibote- 
nate, an NMDA agonist, which is an equally potent activator of PI turnover at this 
age [8], also elicits neuronal damage in immature brain [12]. In contrast, KA, which 
is not toxic in vivo at this age does not stimulate PI turnover. Excessive PI turnover 
may play a role in the pathogenesis of the neuronal damage observed from QA. 
Direct intrahippocampal injection of QA in adult cats causes seizures and preferen- 
FABLE 1 
( 'ROSS-SECTIONAL AREA OF STRIATUM 
All animals received 1-#l injections into the right striatum on day 7. Rat pups were killed on day 12 and 
formalin-fixed frozen sections were prepared. Areas were derived from weights of tracing paper outlines 
of enlarged images of histologic sections; in each lesion 7 analogous sections were measured. Values arc 
expressed as mean_+ S.E.M. For statistical analysis, bilateral control values were combined. *P<0.02, 
** P < 0.001: comparison with control values using Student's t-test. 
n Striatal area (mm 2) 
Left (L) Right (R) A%(I --R/L) 
Control 4 5.42_+0.04 5.27+0.11 + 1.4 ± 2.2 
Quisqualate 6 ~ 4.79+0.09** 4.36±0.14"* - 8 . 9 +  1.9" 
Quisqualate 7 4.91 ± 0.13* 3.80 ± 0.12** - 22.3 ± 2.6** 
+ 1.5 h of 8% O~ 
qn a seventh animal, the lesion was presenl but lhere were too few sections for quantitation. 
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tial damage to pyramidal cells of  CA3 [3]. Since electroencephalograms were not done 
in this study we cannot assess if seizures had a role in the pathogenesis of  neuronal 
damage. However, with other glutamate analogues, there is a poor correlation 
between neurotoxic potency and epileptogenic action and excessive excitation is not 
a sufficient explanation for neuronal degeneration [14]. 
Hypoxia increased tissue damage from QA. In dispersed fetal hippocampal cells 
in culture, excitatory amino acid neurotransmitters mediate hypoxic cell death [9]. 
Excessive stimulation of glutamate receptors may play a critical role in selective neu- 
ronal vulnerability to a variety of  metabolic insults including hypoxia-ischemia, status 
epilepticus and hypoglycemia [7]. In 7-day-old rats, unilateral carotid artery ligation 
followed by 1.5 h of 8% 02 exposure produces focal neuronal damage in forebrain 
ipsilateral to ligation. In this well-characterized small animal model of perinatal 
hypoxic-ischemic brain injury, glutamatergic synaptic function is disrupted: presyn- 
aptic glutamate uptake is markedly inhibited [10] and there are selective reductions 
in density of  postsynaptic glutamate receptors [11]. In adult animal models of 
ischemic brain injury, stimulation of  glutamate release with ischemia has been 
observed using microdialysis [1]. Although such measurements have not yet been 
done in immature animals, excessive glutamate release may also play a role in the 
pathogenesis of  hypoxic-ischemic brain injury at this age. It is noteworthy that the 
histopathologic appearance of  the QA lesions closely resembles the lesions resulting 
from carotid ligation and hypoxic exposure [6]. Use of  intracerebral QA injections 
provides a new method for producing neuronal lesions in the developing brain. 
Our observations suggest that excessive release of endogenous glutamate or analo- 
gous substances could produce neuronal destruction in the immature brain. The data 
support the hypothesis that this mechanism may contribute to the evolution of  brain 
damage from perinatal asphyxia. We speculate that certain regions in the developing 
brain such as the caudate-putamen, globus pailidus and hippocampus, may be tar- 
geted for hypoxic-ischemic damage because they contain high concentrations of spe- 
cific 'QA-preferring' glutamate receptors. 
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